cyclosporine has been researched along with Acute Lymphoid Leukemia in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 42 (42.86) | 18.2507 |
2000's | 32 (32.65) | 29.6817 |
2010's | 21 (21.43) | 24.3611 |
2020's | 3 (3.06) | 2.80 |
Authors | Studies |
---|---|
Arcuri, LJ; Lerner, D; Tavares, RCBDS | 1 |
Chatterjee, G; Kapoor, R; Nivargi, S; Rastogi, N; Sharma, A; Yadav, SP | 1 |
Andolina, JR; Edwards, E; Fountaine, TJ; Mullen, CA; Nunez, L; Qiu, M; Rademacher, B; Schenone, D; Sharma, S | 1 |
Butt, F; McKibbin, M | 1 |
Fang, BJ; Fu, YW; Gui, RR; Li, YF; Li, Z; Lyu, TX; Song, YP; Wang, J; Wei, XD; Yu, FK; Zhang, BL; Zhang, WL; Zhang, YL; Zhao, HF; Zhou, J; Zhou, KS; Zu, YL | 1 |
Basu, D; Dubashi, B; Jaikumar, GR; Krishnamurthy, S; Kumar, CGD; Sandeep, SVD | 1 |
Beato Merino, MJ; Gómez-Fernández, C; Hernández-Maraver, D; Herranz Pinto, P; Maldonado Cid, P; Noguera Morel, L; Sendagorta Cudós, E | 1 |
Cairo, M; Camitta, BM; Carpenter, PA; Chan, KW; Diaz Perez, MA; Doyle, J; Eapen, M; Fraser, C; Gross, TG; He, W; Hitzler, JK; Horan, JT; Kennedy-Nasser, AA; Kitko, C; Kurtzberg, J; Lehmann, L; O'Brien, T; Pulsipher, MA; Smith, FO; Zhang, MJ | 1 |
Durkin, S; Gilhotra, JS; Ng, SK | 1 |
Bao, JA; Ding, XL; Miao, LY; Xue, L; Zhang, JJ; Zhang, WW | 1 |
Beck, J; Gruhn, B; Steinbach, D; Weiss, M; Zintl, F | 1 |
Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
Arcos-Machancoses, JV; Fernández-Navarro, JM; Fuentes-Socorro, C; García-Williams, S; Menor-Serrano, F; Verdeguer-Miralles, A | 1 |
Bertrand, Y; Bleyzac, N; Cuzzubbo, D; Domenech, C; Dubois, V; Garnier, N; Goutagny, MP; Goutelle, S; Grardel, N; Janoly-Duménil, A; Plesa, A; Rénard, C | 1 |
Cheng, MY; Fung, MA; Maverakis, E; Patel, F; Shi, VY; Sultani, H; Wilken, R | 1 |
Rosen, D; Sinno, MG; Wittler, R | 1 |
Eskazan, AE | 1 |
Andrews, LM; Atiq, F; Broers, AE; Doorduijn, JK; Koch, BC; Van Gelder, T; Versmissen, J | 1 |
Ghysdael, J; Lasgi, C; Maragno, AL; Nguyen, J; Rocchetti, F; Tran Quang, C | 1 |
Atsuta, Y; Fukuda, T; Ichinohe, T; Inamoto, Y; Kanamori, H; Murata, M; Ohashi, K; Onishi, Y; Ozawa, Y; Sakai, R; Takahashi, S; Takanashi, M; Terakura, S; Teshima, T; Uchida, N; Wake, A; Yamaguchi, H; Yamaguchi, T | 1 |
Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
Arima, N; Fujiwara, H; Hamada, H; Matsushita, K; Ozaki, A; Tei, C; Yoshimitsu, M | 1 |
Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F | 1 |
Bachanova, V; Brunstein, CG; Burke, MJ; Cao, Q; Sandhu, K; Singleton, TP; Verneris, MR; Wagner, JE; Weisdorf, DJ; Yohe, S | 1 |
Besbas, N; Bilginer, Y; Cetin, M; Gokce, M; Gumruk, F; Ozaltin, F; Ozen, S | 1 |
Liu, H; Liu, X; Liu, Z; Pan, L; Sun, Z; Wang, N; Wang, Z; Wu, J; Wu, S; Zhu, W | 1 |
Bader, P; Beck, LF; Dückers, G; Greil, J; Hoelle, W; Kerst, G; Klingebiel, T; Kreyenberg, H; Lang, P; Niethammer, D | 1 |
Cappelli, B; Dallorso, S; Dini, G; Faraci, M; Fondelli, MP; Gaggero, R; Haupt, R; Lanino, E; Morreale, G | 1 |
Chen, Y; Han, W; Hong, H; Huang, X; Lu, D | 1 |
Chybicka, A; Gorczyñska, E; Kalwak, K; Rybka, B; Ryczan, R; Sajewicz, L; Toporski, J; Turkiewicz, D | 1 |
Bhatia, M; Kher, K; Minniti, CP | 1 |
Arnold, R; Dörken, B; Heine, F; Le Coutre, P; Massenkeil, G; Nagy, M; Rosen, O | 1 |
Chen, H; Chen, YH; Dong, LJ; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Lu, J; Ren, HY; Wang, JB; Wu, T; Xu, LP | 1 |
Chen, PM; Hsiao, LT; Lin, PC | 1 |
Reiter, A; Schrappe, M; Schrauder, A; Sykora, KW; Teuffel, O; Welte, K; Zimmermann, M | 1 |
Storms, DH; Zunino, SJ | 1 |
Aoyama, K; Fujii, N; Hiraki, A; Ikeda, K; Ishimaru, F; Kondo, E; Koyama, M; Masunari, T; Matsuzaki, T; Mizobuchi, S; Shinagawa, K; Tanimoto, M; Teshima, T | 1 |
Fujii, H; Goto, H; Ikuta, K; Isaki, S; Kajiwara, R; Kuroki, F; Takahashi, H; Yanagimachi, M; Yokota, S | 1 |
Chen, SN; Fu, ZZ; Han, Y; He, GS; Jin, ZM; Ma, X; Miao, M; Qiu, HY; Sun, AN; Tang, XW; Wang, Y; Wu, DP; Xue, SL; Zhao, Y | 1 |
Doyle, J; Somech, R | 1 |
Bertz, H; Bley, TA; Feuerhake, F; Finke, J; Mielke, S; Potthoff, K; Windfuhr, M | 1 |
Kinjo, S; Nagasaki, A; Nakachi, S; Takasu, N; Yamanoha, A | 1 |
Al-Jefri, A; Al-Seraihi, A; Ayas, M | 1 |
Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS | 1 |
Gawlicka, G; Giebel, S; Holowiecki, J; Markiewicz, M; Miszczyk, L; Tomaszewska, R; Wojnar, J; Wyleioł, I | 1 |
Bahlis, NJ; Balogh, A; Brown, CB; Chaudhry, MA; Geddes, M; Larratt, L; Quinlan, D; Russell, JA; Savoie, ML; Stewart, DA; Storek, J; Turner, AR | 1 |
Bakhshi, S; Goel, R; Kumar, R | 1 |
Choi, G; Hong, W; Kim, YC; Shin, J; Song, H | 1 |
Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
Baruchel, A; Devergie, A; Esperou Bourdeau, H; Hirsch, I; Moussalem, M; Parquet, N; Ribaud, P; Schaison, G; Socie, G; Traineau, R | 1 |
Boer, R; Ferry, DR; Gekeler, V; Ise, W; Kerr, DJ; Malkhandi, J | 1 |
Hunt, S; Johnson, F | 1 |
Catovsky, D; Horton, C; Mehta, J; Milan, S; Powles, R; Tait, D; Treleaven, J | 1 |
FitzSimon, S; McCann, SR; O'Connor, M; O'Riordan, JM | 1 |
Aschan, J; Ringdén, O | 1 |
Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
Bafundi, P; Chan, CK; Fyles, G; Hyland, RH; Messner, H; Payne, L; Yeung, M | 1 |
Dörries, K; Schneider, EM | 1 |
Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P | 1 |
Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
Bellin, MF; Dion, E; Drahy, G; Faucher, C | 1 |
Bernaud, J; Garin, L; Mérieux, Y; Philippe, N; Rigal, D; Souillet, G | 1 |
Bertoglio, J; Bohuon, C; Bréard, J; Comisso, M; Pallardy, M; Roger, R | 1 |
Baraldo, M; Cossettini, P; Furlanut, M; Pea, F; Wu, G | 1 |
Abboud, MR; Barredo, JC; Hahn, A; Laver, J; Yusuf, U | 1 |
Kawano, E; Kuwabara, S; Nakajima, M; Yoshiyama, Y | 1 |
Andersson, BS; Champlin, RE; Cleary, K; de Lima, M; Dyer, C; Gajewski, JL; Giralt, SA; Khouri, IF; Mehra, R; Moore, DF; Przepiorka, D; Rondón, G; van Besien, KW | 1 |
Carrà, AM; Comoli, P; Di Giulio, G; Di Maggio, EM; Giorgiani, G; Locatelli, F; Maccario, R; Pellegrini, N | 1 |
Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J | 1 |
Pihko, H | 1 |
Behm, FG; Campana, D; Ito, C; Pui, CH; Raimondi, SC; Ribeiro, RC | 1 |
Carriço, MK; Coelho, AM; Klumb, CE; Maia, RC; Noronha, H; Ruimanek, VM; Vasconcelos, FC | 1 |
Li, S; Wang, C; Yao, C | 1 |
Bonetti, F; Locatelli, F; Paolucci, G; Pession, A; Prete, A; Rondelli, R; Zecca, M | 1 |
den Boer, ML; Henze, G; Janka-Schaub, GE; Kazemier, KM; Pieters, R; Veerman, AJ | 1 |
Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
Bogusławska-Jaworska, J; Gorczyńska, E; Słociak, M; Toporski, J | 1 |
Glomstein, A; Gustafsson, G; Jonmundsson, G; Mellander, L; Nysom, K; Ringdén, O; Saarinen-Pihkala, UM; Schroeder, H | 1 |
Fischer, J; Göbel, U; Kögler, G; Niehues, T; Nürnberger, W; Somville, T; Wernet, P | 1 |
Mai, I; Mergenthaler, HG; Naujokat, C; Possinger, K; Schweigert, M; Sezer, O | 1 |
Canterbury, A; Clarke, E; Cornish, JM; Goodman, S; Green, A; Hale, G; Hunt, L; Lankester, A; Marks, DI; Oakhill, A; Pamphilon, DH; Steward, CG; Waldmann, H | 1 |
Ağaoğlu, L; Anak, S; Erdem, S; Gedikoğlu, G; Hacibektaşoğlu, A; Karakaş, Z | 1 |
De Maeseneer, M; Debaere, C; Osteaux, M; Stadnik, T | 1 |
Bonetti, F; Dini, G; Giorgiani, G; Giraldi, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Prete, A; Ripaldi, M; Rondelli, R; Uderzo, C; Zecca, M | 1 |
Akakura, N; Katagiri, M; Kimura, S; Kodaira, J; Sakurai, H; Sato, T; Takemori, N; Toyoshima, N | 1 |
Abe, Y; Choi, I; Hara, K; Inaba, S; Kihara, T; Matsushima, T; Minami, R; Muta, K; Nawata, H; Nishimura, J; Shiratsuchi, M | 1 |
Bracho, F; Cairo, MS; Davenport, V; Houtenbos, I; Killen, R; Shen, V; Slack, R; Suen, Y; van de Ven, C | 1 |
Ebata, K; Hirose, Y; Kim, CG; Masaki, Y; Ogawa, N; Okada, J; Sugai, S; Wano, Y | 1 |
Fujisawa, T; Inui, A; Matsumoto, H; Sekine, I | 1 |
Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
Akan, H; Beksaç, M; Ertürk, S; Güneyli, A; Ikizünal, Y; Ilhan, O; Koç, H; Sardaş, OS | 1 |
Cho, J; Slater, LM; Wetzel, M | 1 |
Cumber, PM; Hoy, T; Jacobs, A; Padua, RA; Tsuruo, T; Whittaker, JA | 1 |
Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M | 1 |
Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
2 review(s) available for cyclosporine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Acute lymphoblastic leukemia in a child with nephrotic syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclosporine; Dexamethasone; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Tacrolimus; Treatment Outcome; Vincristine | 2004 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
12 trial(s) available for cyclosporine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Mycophenolic Acid; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Secondary Prevention; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Chimera; Transplantation, Autologous; Treatment Outcome | 2004 |
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2007 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction | 1997 |
Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group.
Topics: Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 1998 |
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Italy; Leukemia; Male; Neoplasm Recurrence, Local; Nuclear Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk; Tissue Donors; Transplantation Conditioning; Treatment Outcome | 2000 |
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno-
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Leukemia Effect; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Immunotherapy; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Treatment Outcome | 2001 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
84 other study(ies) available for cyclosporine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell tran
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Retrospective Studies; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Haploidentical | 2021 |
Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant.
Topics: Adult; Animals; Cell Line, Tumor; Cell Survival; Child; Cyclosporine; Cytokines; Gene Expression; Hematopoietic Stem Cell Transplantation; Humans; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2021 |
Rare retinal complications of bone marrow transplantation (BMT): a case report.
Topics: Bone Marrow Transplantation; Cyclosporine; Fatal Outcome; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2018 |
Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome | 2019 |
Acute Lymphoblastic Leukemia Occurring Five Years After Onset of Steroid Resistant Nephrotic Syndrome.
Topics: Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteinuria; Rituximab; Steroids | 2019 |
Acral erythema worsened by intravenous infusions of cyclosporin.
Topics: Adult; Antineoplastic Agents; Cyclosporine; Cytarabine; Drug Eruptions; Erythema; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2013 |
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Down Syndrome; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Living Donors; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Registries; Remission Induction; Retrospective Studies; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2014 |
Rapid Resolution of Graft-versus-Host-Disease-Related Central Serous Chorioretinopathy.
Topics: Bone Marrow Transplantation; Central Serous Chorioretinopathy; Cyclosporine; Diarrhea; Exanthema; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Models, Biological; Myelodysplastic Syndromes; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2014 |
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Retrospective Studies; Severity of Illness Index; Siblings; Treatment Outcome; Young Adult | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
Headache, hypertension and seizures.
Topics: Central Nervous System Neoplasms; Child; Cyclosporine; Diagnosis, Differential; Female; Graft vs Host Disease; Headache; Hematopoietic Stem Cell Transplantation; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures | 2015 |
Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Risk; Survival Rate; Tissue Donors; Young Adult | 2016 |
Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event.
Topics: Adult; Biopsy; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sebaceous Gland Diseases; Sebaceous Glands; Stem Cell Transplantation | 2016 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors | 2016 |
Response: Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
Topics: Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines | 2016 |
The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib.
Topics: Animals; Calcineurin; Cyclosporine; Dasatinib; Disease Models, Animal; Leukemia, B-Cell; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Topics: Adolescent; Adult; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Survival Rate; Tacrolimus | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
Topics: Adult; Benzamides; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Living Donors; Lymphocyte Transfusion; Male; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Siblings; Transplantation, Homologous | 2008 |
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Encephalitis, Varicella Zoster; Graft vs Host Disease; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Male; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Time Factors; Virus Activation | 2011 |
Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.
Topics: Adolescent; Anemia, Hemolytic; Antibodies; Anticoagulants; Antiphospholipid Syndrome; Cardiolipins; Child; Child, Preschool; Cyclosporine; Female; Heparin, Low-Molecular-Weight; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukopenia; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Phospholipids; Plasma Exchange; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Thrombotic Microangiopathies; Venous Thrombosis | 2012 |
[Treatment of two case childhood acute lymphoblastic leukemia by HLA-mismatched unrelated umbilical cord blood transplantation].
Topics: Child, Preschool; Cyclosporine; DNA Fingerprinting; DNA, Neoplasm; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning | 2002 |
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Topics: Child; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2002 |
Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity.
Topics: Child; Child, Preschool; Cyclosporine; Epilepsy, Temporal Lobe; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male; Neurotoxins; Osteoporosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sclerosis; Seizures; Stem Cell Transplantation; Transplantation Conditioning | 2003 |
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Contraindications; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infection Control; Infections; Leukemia, Myeloid; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2004 |
Acute polymyositis after donor lymphocyte infusion.
Topics: Cyclosporine; Disease Susceptibility; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-DR Antigens; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Middle Aged; Polymyositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Time Factors; Transplantation Chimera; Transplantation, Homologous | 2005 |
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation, Homologous | 2005 |
Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Isoquinolines; Jurkat Cells; Membrane Potentials; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes | 2006 |
Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pain; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Tacrolimus; Transplantation, Homologous | 2006 |
[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Infant; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tissue Donors; Transplantation Conditioning; Vidarabine | 2006 |
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Fusion Proteins; Survival Rate; Transplantation Conditioning; Young Adult | 2006 |
Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis.
Topics: Adolescent; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudotumor Cerebri; Transplantation, Homologous | 2007 |
Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclosporine; Demyelinating Diseases; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Melphalan; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Assessment; Stem Cell Transplantation; Vidarabine | 2007 |
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mediastinal Emphysema; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Syndrome | 2007 |
In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?
Topics: Child; Cyclosporine; Female; Humans; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Tacrolimus | 2008 |
Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Cochlear Implantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Time Factors; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia.
Topics: Anemia, Refractory; Child; Cyclosporine; Flow Cytometry; Humans; Immunophenotyping; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2007 |
Atypical acute graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Erythema; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Treatment Outcome | 2007 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1995 |
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
Topics: Allosteric Regulation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cell Division; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Mathematics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tritium; Tumor Cells, Cultured; Vinblastine; Vincristine | 1994 |
Recurrent lymphoma in a cardiac allograft recipient.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Homologous | 1994 |
Bone marrow transplantation for primary refractory acute leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Survival Rate | 1994 |
Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclosporine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microcirculation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retinal Vessels | 1994 |
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung Diseases, Obstructive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Risk Factors; Transplantation, Homologous | 1993 |
High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Graft vs Host Disease; Humans; JC Virus; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Probes; Transplantation, Homologous; Tumor Virus Infections | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
[Renal lymphoma in a transplanted patient treated with cyclosporine].
Topics: Cyclosporine; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed | 1993 |
Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
Topics: Autoimmune Diseases; Bone Marrow Transplantation; CD28 Antigens; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transplantation, Autologous; Treatment Outcome | 1996 |
CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis.
Topics: Antibodies, Monoclonal; Apoptosis; B7-1 Antigen; Calcium; CD28 Antigens; Cell Death; Cyclosporine; Cytoplasmic Granules; Cytotoxicity, Immunologic; Exocytosis; Humans; Killer Cells, Natural; Kinetics; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thymoma; Tumor Cells, Cultured | 1996 |
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.
Topics: Adult; Aged; Bayes Theorem; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Least-Squares Analysis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Progressive autologous graft-versus-host disease induced by cyclosporin A.
Topics: Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1996 |
Demyelinating brachial neuropathy complicating syngeneic graft-versus-host disease.
Topics: Adult; Blood Transfusion, Autologous; Brachial Plexus; Cyclosporine; Demyelinating Diseases; Graft vs Host Reaction; Humans; Lymphoma, Non-Hodgkin; Male; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation | 1997 |
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tissue Donors; Transplantation, Homologous | 1997 |
Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effect.
Topics: Adoptive Transfer; Antigens, CD; Child; Colony-Forming Units Assay; Cyclosporine; Fetal Blood; Graft vs Host Reaction; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppression Therapy; Immunosuppressive Agents; Leukocyte Transfusion; Living Donors; Lung; Male; Nuclear Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed; Whole-Body Irradiation | 1997 |
Hypertensive encephalopathy in children with malignant disease.
Topics: Adolescent; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Ischemic Attack, Transient; Occipital Lobe; Parietal Lobe; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome | 1997 |
Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
Topics: Adolescent; Apoptosis; Burkitt Lymphoma; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Hematopoietic Stem Cells; Humans; Infant; Leukemia-Lymphoma, Adult T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Tumor Cells, Cultured | 1998 |
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Child; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Growth Inhibitors; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1997 |
[Detection of multidrug resistance in patients with leukemia by using flow cytometry and RNA in situ hybridization].
Topics: Adult; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression; Genes, MDR; Humans; Immunosuppressive Agents; In Situ Hybridization; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1996 |
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Survival; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Genistein; Humans; In Vitro Techniques; Multidrug Resistance-Associated Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclosporine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1998 |
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Topics: Adolescent; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Female; Finland; Graft vs Host Disease; Humans; Iceland; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome | 1999 |
Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Topics: Cell Culture Techniques; Cells, Cultured; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility Testing; Humans; Immunophenotyping; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1999 |
In vitro and in vivo correlation of cyclosporin A-induced apoptosis in acute lymphoblastic leukemia.
Topics: Adolescent; Apoptosis; Cyclosporine; Dose-Response Relationship, Drug; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Leukocyte Count; Nausea; Paresthesia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1999 |
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.
Topics: Adolescent; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Histocompatibility Testing; HLA-C Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Depletion; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sex Factors; Survival Analysis; T-Lymphocytes; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome | 1999 |
MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report.
Topics: Antineoplastic Agents; Bone Marrow; Cell Survival; Child; Cyclosporine; Drug Screening Assays, Antitumor; Humans; Idarubicin; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Recombinant Proteins; Tumor Cells, Cultured | 1999 |
Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema.
Topics: Adult; Bone Marrow Transplantation; Brain; Brain Edema; Cyclosporine; Diffusion; Graft vs Host Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1999 |
Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A.
Topics: Administration, Oral; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1999 |
[Nonmyeloablative stem cell transplantation with low-dose total body irradiation (200 cGy) for a 55-year-old woman with acute lymphoblastic leukemia].
Topics: Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Whole-Body Irradiation | 2000 |
T-Cell type acute lymphoblastic leukemia following cyclosporin A therapy for aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Cell Transformation, Neoplastic; Clone Cells; Cyclosporine; Gene Rearrangement; Humans; Immunophenotyping; Leukemia, T-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell | 2001 |
Macrophage activation syndrome, the first sign of acute lymphoblastic leukemia in children?
Topics: Child, Preschool; Cyclosporine; Female; Humans; Macrophage Activation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome | 2001 |
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carrier Proteins; Cyclosporine; Drug Resistance; Gene Expression; Humans; Immunophenotyping; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil | 1992 |
Cyclosporin A potentiation of VP-16: production of long-term survival in murine acute lymphatic leukemia.
Topics: Animals; Cyclosporine; Drug Synergism; Etoposide; Female; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred Strains; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Time Factors | 1992 |
Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Chlorambucil; Cyclosporine; Daunorubicin; Drug Resistance; Humans; In Vitro Techniques; Membrane Glycoproteins; Neuraminidase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1991 |
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous | 1991 |